Company

Beijing Beilu Pharmaceutical Co. Ltd

Headquarters: Beijing, China

Employees: 905

SZSE: 300016 +1.24%

Market Cap

CN¥3.37 Billion

CNY as of Jan. 1, 2025

US$462.4 Million

Market Cap History

Beijing Beilu Pharmaceutical Co. Ltd Categories

China Healthcare Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Beijing Beilu Pharmaceutical Co. Ltd market capitalization over time

Evolution of Beijing Beilu Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Beijing Beilu Pharmaceutical Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.

Stocks & Indices

Beijing Beilu Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300016 wb_incandescent

Details

Headquarters:

Maples International Office

Block A, 7th Floor No. 32 Xizhimen North Street Haidian District

Beijing, 100082

China

Phone: 86 10 6262 2266

Fax: 86 10 8262 6933